Rocuronium Bromide
Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Lifestar Pharma LLC | unknown | 4 | SUPPLYING |
| Meitheal Pharmaceuticals Inc. | generic | 4 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | generic | 2 | SUPPLYING |
| Baxter Healthcare Corporation | brand | 2 | SUPPLYING |
| Sagent Pharmaceuticals | generic | 2 | SUPPLYING |
| Solco Healthcare US, LLC | unknown | 2 | SUPPLYING |
| HF Acquisition Co. LLC, DBA HealthFirst | repackager | 2 | SUPPLYING |
| Gland Pharma Limited | generic | 2 | SUPPLYING |
| Medical Purchasing Solutions, LLC | repackager | 2 | SUPPLYING |
| Civica, Inc | unknown | 2 | SUPPLYING |
| Mylan Institutional LLC | unknown | 2 | SUPPLYING |
| ProPharma Distribution | relabeler | 1 | SUPPLYING |
| B. Braun Medical Inc. | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Rocuronium Bromide Injection — reported in shortage by Sagent Pharmaceuticals. Therapeutic category: Anesthesia.
Rocuronium Bromide Injection — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Anesthesia.
Rocuronium Bromide Injection — reported in shortage by Mylan Institutional, a Viatris Company. Therapeutic category: Anesthesia.
Rocuronium Bromide Injection — reported in shortage by Meitheal Pharmaceuticals, Inc.. Therapeutic category: Anesthesia.
Rocuronium Bromide Injection — reported in shortage by Baxter Healthcare. Therapeutic category: Anesthesia.
